BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

UK Tightens Antidepressant Rules, Curbs Wyeth Drug


10/19/2005 5:12:22 PM

British health authorities tightened warnings on popular Prozac-type antidepressants on Monday, urging doctors to use them sparingly and consider non-drug interventions, such as counseling. The Medicines and Healthcare Products Regulatory Agency, which reviewed the medicines after concerns over their safety, said there should be stronger warnings about the risk of withdrawal reactions after ending a course of treatment. Doctors should also, in most cases, prescribe only the lowest recommended dose of selective serotonin re-uptake inhibitors, or SSRIs, and young adults should be monitored closely as a precautionary measure when being treated, it added. No antidepressant is recommended for the initial treatment of mild depression.

Read at Reuters

Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES